{
      "Rank": 1,
      "Acronym": [
            "SCOTS"
      ],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Injections of BMSC retrobulbar (RB), subtenon (ST) and intravenous (IV)",
            "Injections of BMSC retrobulbar, subtenon, intravenous and intravitreal ( IVIT )",
            "Injection of BMSC retrobulbar, subtenon, intravenous and intraocular (IO) with vitrectomy"
      ],
      "ArmGroupInterventionName": [
            "Procedure: RB (Retrobulbar)",
            "Procedure: ST (Subtenon)",
            "Procedure: IV (Intravenous)",
            "Procedure: RB (Retrobulbar)",
            "Procedure: ST (Subtenon)",
            "Procedure: IV (Intravenous)",
            "Procedure: IVIT (Intravitreal)",
            "Procedure: RB (Retrobulbar)",
            "Procedure: ST (Subtenon)",
            "Procedure: IV (Intravenous)",
            "Procedure: IO (Intraocular)"
      ],
      "ArmGroupLabel": [
            "RB, ST, IV",
            "RB, ST, IV, IVIT",
            "RB, ST, IV, IO"
      ],
      "ArmGroupType": [
            "Active Comparator",
            "Active Comparator",
            "Active Comparator"
      ],
      "AvailIPDComment": [
            "http://mdstemcells.com/scots-ii/"
      ],
      "AvailIPDId": [],
      "AvailIPDType": [
            "Clinical Study Report"
      ],
      "AvailIPDURL": [
            "http://mdstemcells.com/scots-ii/"
      ],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT01920867"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease. http://mdstemcells.com/scots-ii/"
      ],
      "BriefTitle": [
            "Stem Cell Ophthalmology Treatment Study"
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "July 2020"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Retinal Disease",
            "Macular Degeneration",
            "Hereditary Retinal Dystrophy",
            "Optic Nerve Disease",
            "Glaucoma"
      ],
      "ConditionAncestorId": [
            "D000005128",
            "D000012162",
            "D000003389"
      ],
      "ConditionAncestorTerm": [
            "Eye Diseases",
            "Retinal Degeneration",
            "Cranial Nerve Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC23",
            "All",
            "BC11",
            "BC10",
            "BC20",
            "BC16",
            "BC14",
            "BC26",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Symptoms and General Pathology",
            "All Conditions",
            "Eye Diseases",
            "Nervous System Diseases",
            "Immune System Diseases",
            "Diseases and Abnormalities at or Before Birth",
            "Heart and Blood Diseases",
            "Wounds and Injuries",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Macular Degeneration",
            "Retinal Disease",
            "Optic Nerve Diseases",
            "Retinal Dystrophy"
      ],
      "ConditionBrowseLeafId": [
            "M15507",
            "M10412",
            "M9695",
            "M27888",
            "M11566",
            "M14151",
            "M7423",
            "M8165",
            "M11320",
            "M3741",
            "M11984",
            "M14160",
            "M14161",
            "M27865",
            "M2147",
            "M1898",
            "M851",
            "M20106",
            "M21200",
            "M28260",
            "M11979",
            "M14149",
            "M5757",
            "T4103",
            "T4945",
            "T5470",
            "T1444",
            "T1446",
            "T1448",
            "T429"
      ],
      "ConditionBrowseLeafName": [
            "Syndrome",
            "Macular Degeneration",
            "Ischemia",
            "Wet Macular Degeneration",
            "Neuromyelitis Optica",
            "Retinal Diseases",
            "Eye Diseases",
            "Glaucoma",
            "Myopia",
            "Atrophy",
            "Optic Nerve Diseases",
            "Retinitis",
            "Retinitis Pigmentosa",
            "Geographic Atrophy",
            "Stargardt Disease",
            "Cone Dystrophy",
            "Cone-Rod Dystrophies",
            "Optic Neuropathy, Ischemic",
            "Optic Nerve Injuries",
            "Retinal Dystrophies",
            "Optic Atrophy",
            "Retinal Degeneration",
            "Cranial Nerve Diseases",
            "Neuromyelitis Optica Spectrum Disorder",
            "Retinitis Pigmentosa",
            "Stargardt Disease",
            "Cone Dystrophy",
            "Cone-rod Dystrophy",
            "Cone-rod Dystrophy 2",
            "Anterior Ischemic Optic Neuropathy"
      ],
      "ConditionBrowseLeafRelevance": [
            "low",
            "high",
            "low",
            "low",
            "low",
            "high",
            "low",
            "low",
            "low",
            "low",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000009422",
            "D000009901",
            "D000008268",
            "D000012164",
            "D000058499"
      ],
      "ConditionMeshTerm": [
            "Nervous System Diseases",
            "Optic Nerve Diseases",
            "Macular Degeneration",
            "Retinal Diseases",
            "Retinal Dystrophies"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Non-Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "Eyes with loss of vision from retinal or optic nerve conditions generally considered irreversible will be treated with a combination of injections of autologous bone marrow derived stem cells isolated from the bone marrow using standard medical and surgical practices. Retinal conditions may include degenerative, ischemic or physical damage ( examples may include macular degeneration, hereditary retinal dystrophies such as retinitis pigmentosa, stargardt, non-perfusion retinopathies, post retinal detachment. Optic Nerve conditions may include degenerative, ischemic or physical damage ( examples may include optic nerve damage from glaucoma, compression, ischemic optic neuropathy, optic atrophy ). Injections may include retrobulbar, subtenon, intravitreal, intraocular, subretinal and intravenous. Patients will be followed for 12 months with serial comprehensive eye examinations including relevant imaging and diagnostic ophthalmic testing."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nHave objective, documented damage to the retina or optic nerve unlikely to improve OR\nHave objective, documented damage to the retina or optic nerve that is progressive\nAND have less than or equal to 20/40 best corrected central visual acuity in one or both eyes AND/OR an abnormal visual field in one or both eyes.\nBe at least 3 months post-surgical treatment intended to treat any ophthalmologic disease and stable.\nIf under current medical therapy ( pharmacologic treatment) for a retinal or optic nerve disease be considered stable on that treatment and unlikely to have visual function improvement ( for example, glaucoma with intraocular pressure stable on topical medications but visual field damage ).\nHave the potential for improvement with BMSC treatment and be at minimal risk of any potential harm from the procedure.\nBe over the age of 18\nBe medically stable and able to be medically cleared by their primary care physician or a licensed primary care practitioner for the procedure. Medical clearance means that in the estimation of the primary care practitioner, the patient can reasonably be expected to undergo the procedure without significant medical risk to health.\n\nExclusion Criteria:\n\nPatients who are not capable of an adequate ophthalmologic examination or evaluation to document the pathology.\nPatients who are not capable or not willing to undergo follow up eye exams with the principle investigator or their ophthalmologist or optometrist as outlined in the protocol.\nPatients who are not capable of providing informed consent.\nPatients who may be at significant risk to general health or to the eyes and visual function should they undergo the procedure."
      ],
      "EnrollmentCount": [
            "300"
      ],
      "EnrollmentType": [
            "Actual"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [
            "No"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "RB, ST, IV",
            "RB, ST, IV, IO",
            "RB, ST, IV, IVIT",
            "RB, ST, IV",
            "RB, ST, IV, IO",
            "RB, ST, IV, IVIT",
            "RB, ST, IV",
            "RB, ST, IV, IO",
            "RB, ST, IV, IVIT",
            "RB, ST, IV, IVIT",
            "RB, ST, IV, IO"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "Retrobulbar injection of Bone Marrow Derived Stem Cells (BMSC)",
            "Subtenon injection of Bone Marrow Derived Stem Cells (BMSC)",
            "Intravenous injection of Bone Marrow Derived Stem Cells (BMSC)",
            "Intravitreal injection of Bone Marrow Derived Stem Cells (BMSC)",
            "Intraocular injection of Bone Marrow Derived Stem Cells (BMSC) with vitrectomy prior to intraocular injection. For example, may include larger amount of stem cells in the intravitreal cavity, intraneuronal injections or subretinal injections of stem cells."
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "RB (Retrobulbar)",
            "ST (Subtenon)",
            "IV (Intravenous)",
            "IVIT (Intravitreal)",
            "IO (Intraocular)"
      ],
      "InterventionOtherName": [
            "Retrobulbar injection of stem cells",
            "Subtenon injection of stem cells",
            "Intravenous injection of stem cells",
            "Intravitreal injection of stem cells",
            "Intraocular injection of stem cells with vitrectomy"
      ],
      "InterventionType": [
            "Procedure",
            "Procedure",
            "Procedure",
            "Procedure",
            "Procedure"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Stem Cells",
            "Bone Marrow Derived Stem Cells",
            "BMSC",
            "BMC (Bone Marrow Cell)",
            "Mesenchymal Stem Cells",
            "MSC",
            "Eye Disease",
            "Eye Stem Cells",
            "Ophthalmology",
            "Ophthalmic Disease",
            "Retina",
            "Retinal Disease",
            "Macular Degeneration",
            "Age Related Macular Degeneration",
            "Myopic Macular Degeneration",
            "Geographic Atrophy",
            "Dry Macular Degeneration",
            "Wet Macular Degeneration",
            "Retinal Atrophy",
            "Retinal Dystrophy",
            "Hereditary Retinal Dystrophy",
            "Retinitis Pigmentosa",
            "Stargardt Disease",
            "Cone Dystrophy",
            "Cone Rod Dystrophy",
            "Maculopathy",
            "Optic Nerve Disease",
            "Optic Nerve Atrophy",
            "Optic Atrophy",
            "Ischemic Optic Neuropathy",
            "Optic Nerve Damage",
            "Optic Nerve Compression",
            "Compressive Optic Neuropathy",
            "Devics Syndrome"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [
            "Enrolling by invitation"
      ],
      "LastUpdatePostDate": [
            "October 23, 2019"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "October 21, 2019"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "MD Stem Cells"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Westport"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "United States"
      ],
      "LocationFacility": [
            "MD Stem Cells"
      ],
      "LocationState": [
            "Connecticut"
      ],
      "LocationStatus": [],
      "LocationZip": [
            "06880"
      ],
      "MaximumAge": [],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Bone Marrow Derived Stem Cell Ophthalmology Treatment Study"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "MD Stem Cells"
      ],
      "OrgStudyId": [
            "ICMS-2013-0019."
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "MD Stem Cells",
            "MD Stem Cells"
      ],
      "OverallOfficialName": [
            "Steven Levy, MD",
            "Jeffrey Weiss, MD"
      ],
      "OverallOfficialRole": [
            "Study Director",
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Unknown status"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Not Applicable"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "July 2020"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "Best corrected visual acuity will be measured with Snellen Eye Chart and the ETDRS (Early Treatment Diabetic Retinopathy Study)Eye Chart when available at each post- procedure visit. Intervals at minimum will be first post- procedure day,then 3 months, 6 months and 12 months post-procedure day. Recommended visit 1 month post -procedure day."
      ],
      "PrimaryOutcomeMeasure": [
            "Visual acuity"
      ],
      "PrimaryOutcomeTimeFrame": [
            "1 day to 12 months"
      ],
      "ReferenceCitation": [
            "Weiss JN, Levy S, Malkin A. Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a preliminary report. Neural Regen Res. 2015 Jun;10(6):982-8. doi: 10.4103/1673-5374.158365.",
            "Weiss JN, Levy S, Benes SC. Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy. Neural Regen Res. 2015 Sep;10(9):1507-15. doi: 10.4103/1673-5374.165525.",
            "Weiss JN, Benes SC, Levy S. Stem Cell Ophthalmology Treatment Study (SCOTS): improvement in serpiginous choroidopathy following autologous bone marrow derived stem cell treatment. Neural Regen Res. 2016 Sep;11(9):1512-1516.",
            "Kasetty MA, Hedges TR 3rd, Witkin AJ. BILATERAL EPIRETINAL MEMBRANE FORMATION AFTER INTRAVITREAL INJECTIONS OF AUTOLOGOUS MESENCHYMAL STEM CELLS. Retin Cases Brief Rep. 2022 Sep 1;16(5):561-564. doi: 10.1097/ICB.0000000000001032.",
            "Weiss JN, Levy S, Benes SC. Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber's hereditary optic neuropathy. Neural Regen Res. 2016 Oct;11(10):1685-1694."
      ],
      "ReferencePMID": [
            "26199618",
            "26604914",
            "27857759",
            "32568958",
            "27904503"
      ],
      "ReferenceType": [
            "result",
            "result",
            "result",
            "derived",
            "derived"
      ],
      "RemovedCountry": [
            "United Arab Emirates"
      ],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "Visual fields will be evaluated with automated perimetry during post- procedure visits as needed and specifically at 6 months and 12 months."
      ],
      "SecondaryOutcomeMeasure": [
            "Visual fields"
      ],
      "SecondaryOutcomeTimeFrame": [
            "1 day to 12 months"
      ],
      "SeeAlsoLinkLabel": [
            "The Role of Patient Funded Clinical Research in Advancing Medical Care"
      ],
      "SeeAlsoLinkURL": [
            "https://mdstemcells.com"
      ],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "August 2012"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "October 2019"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "August 12, 2013"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "August 8, 2013"
      ]
}